It highlights improvements in liposomal formulations, including new lipid compositions, increased stability, optimization of drug release, and the development of structures that facilitate targeted and controlled delivery of treatments, opening up new perspectives in pharmacotherapy
Cardiovascular Protection: Major clinical trials like the LEADER trial for liraglutide have shown that GLP-1 RAs can significantly reduce the risk of major adverse cardiovascular events, such as heart attacks and strokes, in patients with type 2 diabetes
Some researchers also find protein shakes formulated for GLP-1 users particularly helpful for maintaining adequate intake
It feels like a $100 balm for $35
Research-focused suppliers like Protide Health may partner with domestic labs to synthesize researchgrade peptides that are verified by independent third-party laboratories, and for most qualified researchers these vendors, rather than the industrial CDMOs, are the practical source